Fenclonine

Fenclonine

SCHEMBL8710394

N[C@@H](Cc1ccc(Cl)cc1)C(=O)O.N[C@@H](Cc1ccc(I)cc1)C(=O)O.N[C@@H](Cc1ccc(I)cc1)C(=O)O

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.59
PTGS1 P23219 3/20 0.58
ALPI P09923 1/20 0.58
PKM P14618 1/20 0.58
XIAP P98170 1/20 0.58
HIF1A Q16665 5/20 0.52
CYP3A4 P08684 3/20 0.51
ALOX15 P16050 3/20 0.51
ALDH1A1 P00352 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
KDM4E B2RXH2 2/20 0.51
ABCB11 O95342 1/20 0.51
CHRM2 P08172 1/20 0.51
ADRA2A P08913 1/20 0.51
CHRM1 P11229 1/20 0.51
ACHE P22303 1/20 0.51
OPRM1 P35372 1/20 0.51
DRD3 P35462 1/20 0.51
SLC6A3 Q01959 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodofalan SCHEMBL44619 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Iodofalan SCHEMBL44620 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Iodofalan SCHEMBL44618 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL3140768 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL245828 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL26383 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL26382 0.91 SLC7A5 (0.69) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL988270 0.90 SLC7A5 (0.67) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL6357978 0.90 SLC7A5 (0.67) SLC7A5PTGS1ALPIPKMXIAP
Fenclonine SCHEMBL16825893 0.90 SLC7A5 (0.67) SLC7A5PTGS1ALPIPKMXIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807819-A USING AN OLIGOPEPTIDE LA JOLLA CANCER RESEARCH CENTER (US) 1998-09-15 US disclosed
US-5792745-A ADMINISTERING CYCLIC PEPTIDE HAVING GLYCINE-ASPARTIC ACID CORE SEQUENCE LA JOLLA CANCER RESEARCH CENTER (US) 1998-08-11 US disclosed
US-5773412-A USING CYCLIC PEPTIDE LA JOLLA CANCER RESEARCH CENTER (US) 1998-06-30 US disclosed
US-5770565-A AMINO ACID SEQUENCE CONSISTS OF ALTLEAST ONE ARGANINE-GLYCINE-ASPARTIC ACID SEQUENCE; INHIBIT BINDING OF OSTEOCLAST TO A MATRIX SUCH AS BONE LA JOLLA CANCER RESEARCH CENTER (US) 1998-06-23 US disclosed
US-5759996-A REDUCE BONE RESORPTION, ANGIOGENESIS, AND RESTENOSIS LA JOLLA CANCER RESEARCH CENTER (US) 1998-06-02 US disclosed